Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Gianluca Moscato"'
Publikováno v:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 42(7)
Autor:
Lucia Moiola, Maria Buccafusca, Massimiliano Mirabella, BREMSO-group, Valentina Zipoli, Roberto Bergamaschi, Gianluca Moscato, Vincenzo Brescia Morra, Elisabetta Ferraro, Katrin Plewnia, Mauro Zaffaroni, Maria Pia Amato, Giulia Mallucci, Francesco Patti, Maria Trojano, Elisa Puma
Disease modifying therapy have changed the natural evolution of multiple sclerosis (MS), with efficacy demonstrated in randomized clinical trials. Standard-of-care effectiveness is needed to complement clinical trial data and highlight outcomes in re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4636ecaab3c9713fc1583fd29a78ce93
http://hdl.handle.net/20.500.11769/381250
http://hdl.handle.net/20.500.11769/381250
Autor:
Daniele Orsucci, Gianfranco Cafforio, Gianluca Moscato, Alessandro Napolitano, Monica Mazzoni, Marco Margelli
Publikováno v:
Neuroimmunology and Neuroinflammation. 5:7
Autor:
Fabio Giannini, Ferdinando Sartucci, Alessandro Rossi, Gianluca Moscato, Tommaso Bocci, C Rossi, Luigi Murri, Matteo Caleo
Objective: We assessed changes in Motor Units (MU) and extent of MU loss using macro-electromyography (macro-EMG) and Motor Unit Number Estimation (MUNE). Methods: We applied these techniques to a sample of 61 Amyotrophic Lateral Sclerosis (ALS) pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c04aaf68a23bd2cab33cef3c0b934b2e
http://hdl.handle.net/11365/42434
http://hdl.handle.net/11365/42434
Autor:
Elio Scarpini, Maria Pia Amato, Giuseppe Orefice, G. Vacca, Lorenzo De Santi, Pasquale Annunziata, Davide Maimone, Gianluca Moscato, Raffaella Clerici, Emilio Portaccio, Alfonso Iudice, Antonio Giorgio, Valentina Zipoli, Vincenzo Brescia Morra
To assess the role of CSF oligoclonal bands (OB) in determining the clinical outcome in patients with relapsing-remitting multiple sclerosis (RRMS) treated with IFN-β, we carried out a retrospective, multicentre, observational study recruiting 209 R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16f4e3f2aaf8ab8b2450ce542e8f1f9d
http://hdl.handle.net/11365/23607
http://hdl.handle.net/11365/23607
Autor:
Michela Saviozzi, Serena Mosti, Carolina Scagnolari, Ele Ferrannini, Guido Antonelli, Luigi Murri, Gianluca Moscato, A Casolaro, Fabio Monzani, Giuseppe Meucci, Fabrizio Bruschi, Francesco Lombardo, Nadia Caraccio
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 22(7)
Interferon-beta1b (IFN-beta1b) therapy is associated with a relatively high risk of developing thyroid disease. IFN-beta1a is regarded as less immunogenic than IFN-beta1b because of its structural homology to natural IFN-beta. We assessed the effect
Publikováno v:
European journal of neurology. 7(6)
Multiple sclerosis (MS) is a T-cell-mediated autoimmune demyelinating disease of the central nervous system, associated with an altered cytokine network. We previously assayed peripheral blood T-lymphocyte binding for two prototypic cytokines, tumour
Autor:
Serena Mosti, Francesco Lombardo, Maria Rosaria Romano, Gianluca Moscato, Paolo Bongioanni, Giuseppe Meucci
Publikováno v:
European journal of neurology. 7(3)
Multiple sclerosis (MS) represents a T-cell-mediated autoimmune demyelinating disease of the central nervous system associated with altered immunoregulation. Interleukin (IL)-6 is a cytokine that has several effects on the neuroimmune system. Specifi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
European Neuropsychopharmacology. 7:S266-S267